
Blog
Patient Story: Making an Impact in Glioblastoma Treatment
by Guest Author
The research arm at Pacific Neuroscience Institute confronts some of medicine’s biggest brain tumor challenges. Read this story about glioblastoma and the innovative clinical trial treatment a patient received.
Biopsy-Free Analysis of Brain Cancer
by Achal S. Achrol
A recently published paper by Pacific Neuroscience Institute researchers suggests a promising new approach for a biopsy-free method to identify primary brain tumor genetics for personalized treatment options.
Clinical Trials Round Up: March 2019
by Mini Gill
The Clinical Trials Team at Pacific Neuroscience Institute is pleased to announce a new clinical trial this month for post-stroke shoulder pain. Find out about this and more neurological trails.
Clinical Trials Round Up: February 2019
by PNI Experts
The neurosciences clinical trials team is pleased to announce two new clinical trials in Overactive bladder and Alzheimer's disease. Find out more.
Is It Possible To Kick-Start Brain Cell Growth?
by Zara Jethani
Electrical stimulation therapy may have a big impact on brain health and recovery in patients with mood disorders, dementia and neurodegenerative disorders.
Final Call: Unique MDNA55 Glioblastoma Trial Closing Soon
by Zara Jethani
Pacific Neuroscience Institute, the leading enrollment site for the MDNA55 clinical trial for Glioblastoma, is still open and enrolling eligible patients. This innovative phase 2 study is for the minimally invasive convection-enhanced delivery (CED) of a new bioengineered targeted therapeutic, MDNA55, in adults with recurrent or progressive glioblastoma. Read more.
Clinical Trials Round Up: January 2019
by Mini Gill
Pacific Neuroscience Institute opens up two new clinical trials this month, one in Essential Tremor and one in Glioblastoma. Find out more about these new trials as well as the other available open neurological studies.
Essential Tremor Clinical Trial Opens at Pacific Neuroscience Institute
by Giselle Tamula
The Pacific Movement Disorders Center team is excited to announce that we are one of the sites participating in the PROSPECT trial from Cala Health, a three month study for people who have mild to severe essential tremor. The trial is open for patient enrollment.
Clinical Trials Round Up: December 2018
by Mini Gill
Find out about the latest clinical trials at Pacific Neuroscience Institute for brain tumor, stroke, movement disorders, and other neurological areas. Call our center at 310-829-8265 to enroll.
Nativis Announces Publication of Study in Patients with Recurrent Glioblastoma (rGBM)
by Guest Author
Nativis Announces Publication of Study in Patients with Recurrent Glioblastoma (rGBM). Data suggest the Nativis Voyager® device is safe for treatment of rGBM.
Last updated: January 14th, 2019